![Joshua Silverman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joshua Silverman
Algemeen Directeur bij Aromyx Corp.
Profiel
Joshua Silverman is the founder of Versartis, Inc. (founded in 2008), Calysta, Inc. (founded in 2011), and Windfall Bio (founded in 2023).
At Calysta, he held the title of Chief Technology Officer from 2011 to 2016.
At Windfall Bio, he currently holds the title of Chief Executive Officer & Director.
He is also currently the Chief Executive Officer at Aromyx Corp.
Dr. Silverman previously worked as a Director-Process Development at Amgen, Inc., a Scientist at Maxygen, Inc., and a Vice President-Product Development at Amunix, Inc. Dr. Silverman received a doctorate degree from Stanford University and an undergraduate degree from The University of California, San Francisco.
Actieve functies van Joshua Silverman
Bedrijven | Functie | Begin |
---|---|---|
Aromyx Corp.
![]() Aromyx Corp. Packaged SoftwareTechnology Services Aromyx Corp. engages in the using of biological receptors from the human nose to create digital representations of smell sensory data for multiple application. Its products include EssenceChip, EssenceCapture, EssenceAnalytics, and EssenceCloud. The company was founded by Chris Hanson and is headquartered in Palo Alto, CA. | Algemeen Directeur | - |
Windfall Bio
![]() Windfall Bio Chemicals: AgriculturalProcess Industries Windfall Bio, Inc. has developed a solution to capture and transform methane emissions into organic fertilizer. Windfall Bio was founded in 2022 and is based in Menlo Park, CA. This nature-based solution utilizes methane-eating microbes to convert methane from any source into valuable outputs. The company's solution helps reduce the carbon footprint of methane emitters in various industries, including agriculture, oil and gas, and waste management. It also allows farmers to improve profitability and environmental impact. The company is venture-backed by top-tier firms and is focused on naturally transforming methane into organic soil nutrients. Joshua Silverman has been the CEO of the company since 2023. | Oprichter | 01-01-2023 |
Eerdere bekende functies van Joshua Silverman
Bedrijven | Functie | Einde |
---|---|---|
Amunix, Inc.
![]() Amunix, Inc. Pharmaceuticals: MajorHealth Technology Amunix, Inc. develops protein pharmaceuticals. It offers XTEN which is hydrophilic, unstructured, biodegradable polypeptides that impart a number of favorable properties upon the molecules to which they are attached. The company was founded by Volker Schellenberger and Willem Stemmer in 2006 and is headquartered in Mountain View, CA. | Corporate Officer/Principal | - |
AMGEN INC. | Corporate Officer/Principal | - |
Calysta, Inc.
![]() Calysta, Inc. Agricultural Commodities/MillingProcess Industries Calysta, Inc. provides sustainable industrial products for food and energy security. The firm develops new Biological Gas-to-Liquids and Biological Gas-to-Chemicals technologies using methane, the primary component of natural gas. It’s technology allows conversion of a plentiful energy resource into high value chemicals and transportation fuels. The company was founded in 2012 by Joshua Silverman and Alan Shaw and is headquartered in Menlo Park, CA. | Oprichter | - |
Maxygen, Inc.
![]() Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Corporate Officer/Principal | - |
Versartis, Inc.
![]() Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Oprichter | - |
Opleiding van Joshua Silverman
The University of California, San Francisco | Undergraduate Degree |
Stanford University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AMGEN INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Versartis, Inc.
![]() Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
Calysta, Inc.
![]() Calysta, Inc. Agricultural Commodities/MillingProcess Industries Calysta, Inc. provides sustainable industrial products for food and energy security. The firm develops new Biological Gas-to-Liquids and Biological Gas-to-Chemicals technologies using methane, the primary component of natural gas. It’s technology allows conversion of a plentiful energy resource into high value chemicals and transportation fuels. The company was founded in 2012 by Joshua Silverman and Alan Shaw and is headquartered in Menlo Park, CA. | Process Industries |
Maxygen, Inc.
![]() Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |
Amunix, Inc.
![]() Amunix, Inc. Pharmaceuticals: MajorHealth Technology Amunix, Inc. develops protein pharmaceuticals. It offers XTEN which is hydrophilic, unstructured, biodegradable polypeptides that impart a number of favorable properties upon the molecules to which they are attached. The company was founded by Volker Schellenberger and Willem Stemmer in 2006 and is headquartered in Mountain View, CA. | Health Technology |
Aromyx Corp.
![]() Aromyx Corp. Packaged SoftwareTechnology Services Aromyx Corp. engages in the using of biological receptors from the human nose to create digital representations of smell sensory data for multiple application. Its products include EssenceChip, EssenceCapture, EssenceAnalytics, and EssenceCloud. The company was founded by Chris Hanson and is headquartered in Palo Alto, CA. | Technology Services |
Windfall Bio
![]() Windfall Bio Chemicals: AgriculturalProcess Industries Windfall Bio, Inc. has developed a solution to capture and transform methane emissions into organic fertilizer. Windfall Bio was founded in 2022 and is based in Menlo Park, CA. This nature-based solution utilizes methane-eating microbes to convert methane from any source into valuable outputs. The company's solution helps reduce the carbon footprint of methane emitters in various industries, including agriculture, oil and gas, and waste management. It also allows farmers to improve profitability and environmental impact. The company is venture-backed by top-tier firms and is focused on naturally transforming methane into organic soil nutrients. Joshua Silverman has been the CEO of the company since 2023. | Process Industries |